30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

VBI Vaccines (Delaware) Inc (VBIV)

Track

Stock chart
Ticker: VBIV Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GILLIS STEVEN
1 purchase — total 1,004,999 USD
Buy 10 Jul 2023
Value US$4,761,463.04 | Price 290.40 | Shares 64,289
Sale 6 Apr 2023
Value US$2,233,250.03 | Price 265.26 | Shares 6,874
Sale 5 Apr 2023
Value US$238,233.19 | Price 0.13 | Shares 1,832,563
Sale 4 Apr 2023
Value US$769,699.68 | Price 0.16 | Shares 4,810,623
Buy 3 Dec 2021
Value US$20,083.44 | Price 2.45 | Shares 8,200
Sale 1 Dec 2021
Value US$8,961,702.53 | Price 3.31 | Shares 2,707,463
Buy 24 Apr 2020
Value US$9,999,999.90 | Price 1.10 | Shares 9,090,909
Buy 4 Oct 2019
Value US$20,000.00 | Price 0.50 | Shares 40,000
Buy 1 Oct 2019
Value US$4,822.00 | Price 0.48 | Shares 10,000
Buy 1 Oct 2019
Value US$5,676.00 | Price 0.47 | Shares 12,000
Buy 30 Sep 2019
Value US$7,250.00 | Price 0.50 | Shares 14,500
Buy 30 Sep 2019
Value US$75,450.00 | Price 0.50 | Shares 150,000
Buy 23 Sep 2019
Value US$10,000,000.00 | Price 0.50 | Shares 20,000,000
Buy 19 Sep 2019
Value US$5,000,000.00 | Price 0.50 | Shares 10,000,000
Buy 27 Jun 2019
Value US$8,560.00 | Price 1.07 | Shares 8,000
Buy 20 Jun 2019
Value US$37,380.00 | Price 0.89 | Shares 42,000
Buy 20 Jun 2019
Value US$7,800.00 | Price 0.78 | Shares 10,000
Buy 19 Jun 2019
Value US$5,885.60 | Price 0.74 | Shares 8,000
Buy 19 Jun 2019
Value US$105,336.00 | Price 0.73 | Shares 144,000
Buy 18 Jun 2019
Value US$650,000.00 | Price 0.65 | Shares 1,000,000
Buy 17 Jun 2019
Value US$618,000.00 | Price 0.62 | Shares 1,000,000
Buy 17 Dec 2018
Value US$259,999.60 | Price 1.40 | Shares 185,714
Buy 17 Dec 2018
Value US$464,000.60 | Price 1.40 | Shares 331,429
Buy 17 Dec 2018
Value US$417,803.40 | Price 1.40 | Shares 298,431
Buy 17 Dec 2018
Value US$858,195.80 | Price 1.40 | Shares 612,997
Buy 13 Dec 2018
Value US$19,999,999.60 | Price 1.40 | Shares 14,285,714
Buy 6 Aug 2018
Value US$15,607.08 | Price 1.93 | Shares 8,100
Buy 3 Aug 2018
Value US$12,600.00 | Price 2.10 | Shares 6,000
Buy 3 Aug 2018
Value US$27,110.70 | Price 2.01 | Shares 13,500
Buy 3 Aug 2018
Value US$4,011.40 | Price 2.01 | Shares 2,000
Buy 2 Aug 2018
Value US$6,600.00 | Price 2.20 | Shares 3,000
Buy 31 Jul 2018
Value US$38,236.80 | Price 2.28 | Shares 16,800
Buy 24 May 2018
Value US$32,890.00 | Price 2.99 | Shares 11,000
Buy 11 May 2018
Value US$20,661.00 | Price 2.91 | Shares 7,100
Buy 11 May 2018
Value US$14,085.00 | Price 3.13 | Shares 4,500
Buy 11 May 2018
Value US$16,390.00 | Price 2.98 | Shares 5,500
Buy 12 Dec 2017
Value US$17,882.92 | Price 3.88 | Shares 4,609
Buy 12 Dec 2017
Value US$20,970.99 | Price 3.89 | Shares 5,391
Buy 28 Nov 2017
Value US$71,250.00 | Price 4.75 | Shares 15,000
Buy 30 Oct 2017
Value US$2,000,000.90 | Price 3.05 | Shares 655,738
Buy 30 Oct 2017
Value US$915,000.00 | Price 3.05 | Shares 300,000
Buy 30 Oct 2017
Value US$9,455,000.00 | Price 3.05 | Shares 3,100,000
Buy 26 Oct 2017
Value US$9,455,000.00 | Price 3.05 | Shares 3,100,000
Buy 21 Aug 2017
Value US$32,200.00 | Price 3.22 | Shares 10,000
Buy 21 Aug 2017
Value US$9,510.00 | Price 3.17 | Shares 3,000
Buy 10 Aug 2017
Value US$32,800.00 | Price 3.28 | Shares 10,000
Buy 6 Dec 2016
Value US$10,321,062.75 | Price 3.05 | Shares 3,383,955
Buy 14 Aug 2015
Value US$1,352,000.00 | Price 2.08 | Shares 650,000
Buy 30 Sep 2013
Value US$3,420.51 | Price 1.13 | Shares 3,027
Buy 21 Aug 2013
Value US$2,170.30 | Price 1.10 | Shares 1,973
Buy 20 Aug 2013
Value US$6,000.00 | Price 1.20 | Shares 5,000
Buy 20 Aug 2013
Value US$2,360.00 | Price 1.18 | Shares 2,000
Buy 9 Apr 2012
Value US$23,000.00 | Price 1.15 | Shares 20,000
Buy 2 Apr 2012
Value US$21,960.00 | Price 1.10 | Shares 20,000
Buy 19 Mar 2012
Value US$25,040.00 | Price 1.25 | Shares 20,000
Buy 12 Mar 2012
Value US$7,679.00 | Price 1.10 | Shares 7,000
Buy 13 Nov 2009
Value US$8,100.00 | Price 1.35 | Shares 6,000
Sale 13 Oct 2009
Value US$2,392.05 | Price 1.59 | Shares 1,500
Sale 15 Sep 2009
Value US$761.90 | Price 1.90 | Shares 401
Sale 2 Sep 2009
Value US$31,394.40 | Price 1.96 | Shares 16,029
Sale 31 Aug 2009
Value US$1,168.05 | Price 1.95 | Shares 599
Sale 28 Aug 2009
Value US$1,995.15 | Price 1.95 | Shares 1,022
Sale 27 Aug 2009
Value US$3,313.05 | Price 1.95 | Shares 1,699
Sale 26 Aug 2009
Value US$3,047.85 | Price 1.95 | Shares 1,563
Sale 25 Aug 2009
Value US$563.55 | Price 1.95 | Shares 289
Sale 14 Aug 2009
Value US$17,203.44 | Price 2.00 | Shares 8,600
Sale 13 Aug 2009
Value US$3,010.00 | Price 2.15 | Shares 1,400
Sale 12 Aug 2009
Value US$2,500.00 | Price 2.50 | Shares 1,000
Sale 29 Feb 2008
Value US$6,168.30 | Price 4.99 | Shares 1,237
Sale 24 Jan 2008
Value US$5,650.00 | Price 5.65 | Shares 1,000
Sale 9 Jan 2008
Value US$5,150.00 | Price 5.15 | Shares 1,000
Sale 14 Dec 2007
Value US$4,500.00 | Price 5.00 | Shares 900
Sale 14 Dec 2007
Value US$500.00 | Price 5.00 | Shares 100
Sale 4 Oct 2007
Value US$5,203.00 | Price 5.20 | Shares 1,000
Sale 21 Jun 2007
Value US$2,613.40 | Price 5.23 | Shares 500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-18 2023-07-10 B Purchase
GILLIS STEVEN
Non-Executive Director
64,289 -22.8%
290.40
US$4,761,463 		64,289 -22.8% 290.40 US$4,761,463
2023-04-06 2023-04-06 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
6,874 +25.2%
265.26
US$2,233,250 		6,874 +25.2% 265.26 US$2,233,250
2023-04-06 2023-04-05 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
51,179 +18.8%
250.20
US$1,227,635 		51,179 +18.8% 250.20 US$1,227,635
2023-04-06 2023-04-04 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
4,810,623 -9.2%
0.16
US$769,700 		4,810,623 -9.2% 0.16 US$769,700
2021-12-06 2021-12-03 B Purchase
Beattie Nell

Chief Business Officer

Officer
8,200 +13.7%
2.45
US$20,083 		8,200 +13.7% 2.45 US$20,083
2021-12-03 2021-12-01 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
2,707,463 -4.9%
3.31
US$8,961,703 		2,707,463 -4.9% 3.31 US$8,961,703
2020-04-28 2020-04-24 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
9,090,909 +19.8%
1.10
US$10,000,000 		9,090,909 +19.8% 1.10 US$10,000,000
2019-10-07 2019-10-04 B Purchase
Diaz-Mitoma Francisco

Chief Medical Officer
40,000 +51.6%
0.50
US$20,000 		40,000 +51.6% 0.50 US$20,000
2019-10-01 2019-10-01 B Purchase
Beattie Nell

Chief Business Officer
10,000 +20.0%
0.48
US$4,822 		10,000 +20.0% 0.48 US$4,822
2019-10-01 2019-10-01 B Purchase
McNulty Christopher

CFO and Head of BD

Executive Director
12,000 +48.0%
0.47
US$5,676 		12,000 +48.0% 0.47 US$5,676
2019-10-07 2019-09-30 B Purchase
Diaz-Mitoma Francisco

Chief Medical Officer
14,500 +inf%
0.50
US$7,250 		14,500 +inf% 0.50 US$7,250
2019-09-30 2019-09-30 B Purchase
Baxter Jeff

CEO, President

Executive Director
150,000 +32.7%
0.50
US$75,450 		150,000 +32.7% 0.50 US$75,450
2019-09-24 2019-09-23 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
20,000,000 +77.1%
0.50
US$10,000,000 		20,000,000 +77.1% 0.50 US$10,000,000
2019-09-23 2019-09-19 B Purchase
GILLIS STEVEN
10,000,000 +330.5%
0.50
US$5,000,000 		10,000,000 +330.5% 0.50 US$5,000,000
2019-07-01 2019-06-27 B Purchase
Diaz-Mitoma Francisco

Chief Medical Officer
8,000 +11.5%
1.07
US$8,560 		8,000 +11.5% 1.07 US$8,560
2019-06-20 2019-06-20 B Purchase
Diaz-Mitoma Francisco

Chief Medical Officer
42,000 +152.7%
0.89
US$37,380 		42,000 +152.7% 0.89 US$37,380
2019-06-20 2019-06-20 B Purchase
Diaz-Mitoma Francisco

Chief Medical Officer
10,000 +57.1%
0.78
US$7,800 		10,000 +57.1% 0.78 US$7,800
2019-06-19 2019-06-19 B Purchase
Beattie Nell

Chief Business Officer
8,000 +19.0%
0.74
US$5,886 		8,000 +19.0% 0.74 US$5,886
2019-06-19 2019-06-19 B Purchase
Baxter Jeff

CEO, President

Executive Director
144,000 +45.8%
0.73
US$105,336 		144,000 +45.8% 0.73 US$105,336
2019-06-20 2019-06-18 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
1,000,000 +4.0%
0.65
US$650,000 		1,000,000 +4.0% 0.65 US$650,000
2019-06-18 2019-06-17 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
1,000,000 +4.2%
0.62
US$618,000 		1,000,000 +4.2% 0.62 US$618,000
2018-12-18 2018-12-17 B Purchase Kariv Tomer Non-Executive Director
185,714 +inf%
1.40
US$260,000 		185,714 +inf% 1.40 US$260,000
2018-12-18 2018-12-17 B Purchase Kariv Tomer Non-Executive Director
331,429 +54.2%
1.40
US$464,001 		331,429 +54.2% 1.40 US$464,001
2018-12-18 2018-12-17 B Purchase Kariv Tomer Non-Executive Director
298,431 +54.2%
1.40
US$417,803 		298,431 +54.2% 1.40 US$417,803
2018-12-18 2018-12-17 B Purchase Kariv Tomer Non-Executive Director
612,997 +54.2%
1.40
US$858,196 		612,997 +54.2% 1.40 US$858,196
2018-12-17 2018-12-13 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
14,285,714 +152.9%
1.40
US$20,000,000 		14,285,714 +152.9% 1.40 US$20,000,000
2018-08-07 2018-08-06 B Purchase Baxter Jeff

CEO, President

Executive Director
8,100 +3.6%
1.93
US$15,607 		8,100 +3.6% 1.93 US$15,607
2018-08-06 2018-08-03 B Purchase Diaz-Mitoma Francisco

Chief Medical Officer

Officer
6,000 +52.2%
2.10
US$12,600 		6,000 +52.2% 2.10 US$12,600
2018-08-06 2018-08-03 B Purchase Baxter Jeff

CEO, President

Executive Director
13,500 +6.4%
2.01
US$27,111 		13,500 +6.4% 2.01 US$27,111
2018-08-03 2018-08-03 B Purchase Beattie Nell

Chief Business Officer

Officer
2,000 +10.7%
2.01
US$4,011 		2,000 +10.7% 2.01 US$4,011
2018-08-06 2018-08-02 B Purchase Diaz-Mitoma Francisco

Chief Medical Officer

Officer
3,000 +35.3%
2.20
US$6,600 		3,000 +35.3% 2.20 US$6,600
2018-08-01 2018-07-31 B Purchase Baxter Jeff

CEO, President

Executive Director
16,800 +8.6%
2.28
US$38,237 		16,800 +8.6% 2.28 US$38,237
2018-05-25 2018-05-24 B Purchase Baxter Jeff

CEO, President

Executive Director
11,000 +7.2%
2.99
US$32,890 		11,000 +7.2% 2.99 US$32,890
2018-05-14 2018-05-11 B Purchase Baxter Jeff

CEO, President

Executive Director
7,100 +4.9%
2.91
US$20,661 		7,100 +4.9% 2.91 US$20,661
2018-05-14 2018-05-11 B Purchase Diaz-Mitoma Francisco

Chief Medical Officer

Officer
4,500 +1.7%
3.13
US$14,085 		4,500 +1.7% 3.13 US$14,085
2018-05-14 2018-05-11 B Purchase Diaz-Mitoma Francisco

Chief Medical Officer

Officer
5,500 +183.3%
2.98
US$16,390 		5,500 +183.3% 2.98 US$16,390
2017-12-13 2017-12-12 B Purchase Baxter Jeff

CEO, President

Executive Director
4,609 +3.3%
3.88
US$17,883 		4,609 +3.3% 3.88 US$17,883
2017-12-13 2017-12-12 B Purchase Baxter Jeff

CEO, President

Executive Director
5,391 +4.0%
3.89
US$20,971 		5,391 +4.0% 3.89 US$20,971
2017-11-29 2017-11-28 B Purchase Baxter Jeff

CEO, President

Executive Director
15,000 +12.5%
4.75
US$71,250 		15,000 +12.5% 4.75 US$71,250
2017-11-01 2017-10-30 B Purchase Opko Health, Inc. Large shareholder
655,738 +10.9%
3.05
US$2,000,001 		655,738 +10.9% 3.05 US$2,000,001
2017-10-31 2017-10-30 B Purchase GILLIS STEVEN
300,000 +11.0%
3.05
US$915,000 		300,000 +11.0% 3.05 US$915,000
2017-10-31 2017-10-30 B Purchase CHAWLA SAM
3,100,000 +49.6%
3.05
US$9,455,000 		3,100,000 +49.6% 3.05 US$9,455,000
2017-10-30 2017-10-26 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
3,100,000 +49.6%
3.05
US$9,455,000 		3,100,000 +49.6% 3.05 US$9,455,000
2017-08-22 2017-08-21 B Purchase Baxter Jeff

CEO, President

Executive Director
10,000 +9.1%
3.22
US$32,200 		10,000 +9.1% 3.22 US$32,200
2017-08-22 2017-08-21 B Purchase Diaz-Mitoma Francisco

Chief Medical Officer
3,000 +inf%
3.17
US$9,510 		3,000 +inf% 3.17 US$9,510
2017-08-14 2017-08-10 B Purchase Baxter Jeff

CEO, President

Executive Director
10,000 +10.0%
3.28
US$32,800 		10,000 +10.0% 3.28 US$32,800
2016-12-08 2016-12-06 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
3,383,955 +119.6%
3.05
US$10,321,063 		3,383,955 +119.6% 3.05 US$10,321,063
2015-08-18 2015-08-14 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
650,000 +24.9%
2.08
US$1,352,000 		650,000 +24.9% 2.08 US$1,352,000
2013-10-07 2013-09-30 B Purchase Smith Murray George

Chief Financial Officer

Officer
3,027 +33.7%
1.13
US$3,421 		3,027 +33.7% 1.13 US$3,421
2013-08-22 2013-08-21 B Purchase Smith Murray George

Chief Financial Officer

Officer
1,973 +28.2%
1.10
US$2,170 		1,973 +28.2% 1.10 US$2,170
2013-08-22 2013-08-20 B Purchase Smith Murray George

Chief Financial Officer

Officer
5,000 +250.0%
1.20
US$6,000 		5,000 +250.0% 1.20 US$6,000
2013-08-22 2013-08-20 B Purchase Smith Murray George

Chief Financial Officer

Officer
2,000 +inf%
1.18
US$2,360 		2,000 +inf% 1.18 US$2,360
2012-04-11 2012-04-09 B Purchase Pratt Shannon Non-Executive Director
20,000 +33.3%
1.15
US$23,000 		20,000 +33.3% 1.15 US$23,000
2012-04-11 2012-04-02 B Purchase Pratt Shannon Non-Executive Director
20,000 +50.0%
1.10
US$21,960 		20,000 +50.0% 1.10 US$21,960
2012-04-11 2012-03-19 B Purchase Pratt Shannon Non-Executive Director
20,000 +100.0%
1.25
US$25,040 		20,000 +100.0% 1.25 US$25,040
2012-04-11 2012-03-12 B Purchase Pratt Shannon Non-Executive Director
7,000 +77.3%
1.10
US$7,679 		7,000 +77.3% 1.10 US$7,679
2009-11-17 2009-11-13 B Purchase Pratt Shannon Non-Executive Director
6,000 +39.5%
1.35
US$8,100 		6,000 +39.5% 1.35 US$8,100
2009-12-31 2009-10-13 S Sale McChesney Shawn
1,500 -100.0%
1.59
US$2,392 		1,500 -100.0% 1.59 US$2,392
2009-09-17 2009-09-15 S Sale PAULSON CHESTER L F

Chairman

Executive Director Large shareholder
401 -0.0%
1.90
US$762 		401 -0.0% 1.90 US$762
2009-09-03 2009-09-02 S Sale PAULSON CHESTER L F

Chairman

Executive Director Large shareholder
16,029 -0.5%
1.96
US$31,394 		16,029 -0.5% 1.96 US$31,394
2009-09-01 2009-08-31 S Sale PAULSON CHESTER L F

Chairman

Executive Director Large shareholder
599 -0.0%
1.95
US$1,168 		599 -0.0% 1.95 US$1,168
2009-09-01 2009-08-28 S Sale PAULSON CHESTER L F

Chairman

Executive Director Large shareholder
1,022 -0.0%
1.95
US$1,995 		1,022 -0.0% 1.95 US$1,995
2009-08-27 2009-08-27 S Sale PAULSON CHESTER L F

Chairman

Executive Director Large shareholder
1,699 -0.1%
1.95
US$3,313 		1,699 -0.1% 1.95 US$3,313
2009-08-27 2009-08-26 S Sale PAULSON CHESTER L F

Chairman

Executive Director Large shareholder
1,563 -0.1%
1.95
US$3,048 		1,563 -0.1% 1.95 US$3,048
2009-08-27 2009-08-25 S Sale PAULSON CHESTER L F

Chairman

Executive Director Large shareholder
289 -0.0%
1.95
US$564 		289 -0.0% 1.95 US$564
2009-08-14 2009-08-14 S Sale PAULSON CHESTER L F

Chairman

Executive Director Large shareholder
8,600 -0.3%
2.00
US$17,203 		8,600 -0.3% 2.00 US$17,203
2009-08-14 2009-08-13 S Sale PAULSON CHESTER L F

Chairman

Executive Director Large shareholder
1,400 -0.0%
2.15
US$3,010 		1,400 -0.0% 2.15 US$3,010
2009-09-01 2009-08-12 S Sale PAULSON CHARLES Non-Executive Director
1,000 -100.0%
2.50
US$2,500 		1,000 -100.0% 2.50 US$2,500
2008-03-05 2008-02-29 S Sale STRIPLIN HARRY L
1,237 -4.3%
4.99
US$6,168 		1,237 -4.3% 4.99 US$6,168
2008-01-24 2008-01-24 S Sale STRIPLIN HARRY L
1,000 -3.3%
5.65
US$5,650 		1,000 -3.3% 5.65 US$5,650
2008-01-10 2008-01-09 S Sale STRIPLIN HARRY L
1,000 -3.2%
5.15
US$5,150 		1,000 -3.2% 5.15 US$5,150
2007-12-18 2007-12-14 S Sale STRIPLIN HARRY L
900 -2.8%
5.00
US$4,500 		900 -2.8% 5.00 US$4,500
2007-12-18 2007-12-14 S Sale STRIPLIN HARRY L
100 -0.3%
5.00
US$500 		100 -0.3% 5.00 US$500
2007-10-04 2007-10-04 S Sale MAXFIELD MARGARET L
1,000 -10.9%
5.20
US$5,203 		1,000 -10.9% 5.20 US$5,203
2007-06-22 2007-06-21 S Sale MAXFIELD MARGARET L
500 -5.2%
5.23
US$2,613 		500 -5.2% 5.23 US$2,613
Explore more

More insider trading research around VBI Vaccines (Delaware) Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America